YSB Inc
Company Profile
Business description
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Group mainly engaged in i) wholesales of pharmaceutical and healthcare products offline or online through its online platform; ii) retail of pharmaceutical and healthcare products through its retail shops; iii) operating online platform that enable the pharmaceutical distributors and vendors to sell their own pharmaceutical and healthcare products using the Group’s online platform; iv) providing SaaS solution to downstream pharmacies to streamline their inventory management; and v) providing medical testing services to primary healthcare institutions. The Group principally operates in the PRC and generates the majority of its revenues from the PRC.
Contact
No. 8 Brand Street, No. 397 Xingang Middle Road
Yaoshibang Building
TIT Creative Industry Zone
Guangzhou
CHNT: +86 4001180958
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 December 2025
Employees
6,620
Stocks News & Analysis
stocks
Qantas earnings: Jetstar capitalising on weaker domestic competition
stocks
Nvidia Earnings: No signs of a slowdown in demand for AI chips
stocks
ASX results reaction: WiseTech, Woolies, Sigma and more
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,196.80 | 20.60 | -0.22% |
CAC 40 | 7,703.90 | 58.70 | -0.76% |
DAX 40 | 23,902.21 | 137.71 | -0.57% |
Dow JONES (US) | 45,544.88 | 92.02 | -0.20% |
FTSE 100 | 9,187.34 | 29.48 | -0.32% |
HKSE | 25,614.73 | 537.11 | 2.14% |
NASDAQ | 21,455.55 | 249.61 | -1.15% |
Nikkei 225 | 42,188.79 | 529.68 | -1.24% |
NZX 50 Index | 13,070.45 | 139.72 | 1.08% |
S&P 500 | 6,460.26 | 41.60 | -0.64% |
S&P/ASX 200 | 8,927.70 | 21.10 | -0.24% |
SSE Composite Index | 3,873.38 | 15.46 | 0.40% |